Clinical Governance, Safety and Oversight Framework at Jintara

Jintara Rehab is a private, adult-only residential addiction treatment and dual-diagnosis centre operated by Lanna Health Care Company Limited, registered under Thai Ministry of Public Health licence SFD 50:13-106 as Jintara Wellness Center and Rehab. Initial registration as a drug rehabilitation centre under the Narcotics Code was granted on 8 September 2013. The current Jintara program opened in January 2022.

Regulatory oversight sits with the Ministry of Public Health Secretariat Office of the Drug Addiction Treatment and Rehabilitation Committee. Licence documentation is available on request from admissions. The registered street address is 76 Moo 5 Pa Dat, Sanphakwan, Hang Dong, Chiang Mai 50100, Thailand. Tax ID and legal-entity details are published in the site footer.

Jintara structures psychiatric oversight through board-certified addiction psychiatrists at Bangkok Hospital Chiang Mai and Chiang Mai Ram Hospital rather than holding psychiatrists on staff, keeping oversight independent with no single-physician dependency. On-site assessment on admission, per SAMHSA TIP 45 residential detox guidance, produces a signed detox plan and medication schedule before the client's first night.

On-site clinical operations are led by Khun Khwan, Head Nurse and Operations Manager, who runs the 24/7 awake nursing rota and co-signs hospital referrals. Jintara holds formal medical care agreements with two partner hospitals in Chiang Mai, dated February 2026 and May 2025 respectively, both compliant with the Thai Personal Data Protection Act (PDPA 2562/2019). The medical-oversight approach follows NIAAA guidelines on medically supervised detoxification.

Jintara uses five validated clinical instruments at admission and throughout detox to quantify withdrawal severity and mental-health acuity: CIWA-Ar, COWS, PHQ-9, GAD-7, and 8Q. Scored thresholds drive nursing assessment frequency and trigger hospital escalation when required. The CIWA-Ar scale, validated by Sullivan et al. in the British Journal of Addiction, remains the standard measure for alcohol withdrawal monitoring.

Every detox plan at Jintara is written by the admitting psychiatrist on Day 1, informed by substance history, physical examination, and Day 2 hospital workup at Bangkok Hospital Chiang Mai. SAMHSA TIP 45 residential detox protocols guide individual plan adjustments for polysubstance use, co-occurring conditions, and psychiatric risk factors. Detox never runs in isolation: the medical detox program integrates therapy from Day 1.

Jintara holds formal hospital care agreements with Bangkok Hospital Chiang Mai (signed February 2026, credit-backed emergency referral) and Chiang Mai Ram Hospital (signed May 2025, two-year term), both governed by the Thai Personal Data Protection Act 2562. SAMHSA TIP 45 identifies documented hospital escalation pathways as a requirement for facilities managing medical withdrawal risk.

When a client's clinical symptoms exceed what can be safely managed on site, the on-duty nursing team escalates to the appropriate partner hospital without delay. Escalation triggers include symptom severity crossing pre-agreed thresholds, vital-sign changes outside safe ranges, cardiac or neurological warning signs, and any patient-reported pain or distress that clinical judgement flags as worth hospital eyes. Transfer decisions are authorised by the psychiatrist on duty.

Jintara maintains approximately 3.2 staff per client, with 32 staff supporting a maximum of ten clients at any time. SAMHSA TIP 45 guidelines for residential detox recommend around-the-clock awake nursing for facilities managing medical withdrawal. At Jintara, vital-sign checks run every four to six hours during active detox and every one to two hours when CIWA-Ar or COWS scores are elevated.

Jintara obtains informed consent on admission covering the program structure, medication plan, Thai PDPA data handling, confidentiality limits, and the right to leave except where clinically contraindicated. SAMHSA TIP 42 guidance on co-occurring disorder treatment identifies fully voluntary, consent-based care as the clinical standard. Consent at Jintara is revisited whenever the treatment plan materially changes.

Confidentiality is governed by the Thai Personal Data Protection Act 2562 (2019). Family contact during treatment is permitted only with the client's written consent, and third-party disclosures (employers, referrers, legal counsel) are routed through the Clinical Director. Co-occurring medical and psychiatric conditions are documented at admission and managed jointly with the partner-hospital teams. Where a condition falls outside Jintara's operational scope, referral out is preferred to accepting a poor clinical fit.

Transparency about scope is a core part of Jintara's clinical governance. The facility operates within a defined clinical envelope, and admissions will refer when a prospective client's needs fall outside it. NIDA's principles of effective treatment include treatment matching as core: connecting clients with programs suited to their specific clinical needs produces consistently better outcomes.